Apple Health billing code update for take-home naloxone

Having trouble viewing this email? View it as a Web page.

Health Care Authority (HCA) logo

How do I bill for take-home naloxone?

HCA has updated billing codes for take-home naloxone for Apple Health Fee-For-Service (FFS) clients. The codes are retroactive to dates of service on and after January 1, 2022.

Hospital EDs, opioid treatment programs and certified or licensed BHAs may be reimbursed for prepackaged opioid overdose reversal medication, naloxone, distributed to clients at risk of an opioid overdose. Naloxone distributed to Apple Health Fee-For-Service (FFS) clients may be billed as a separate line item with one of the following HCPCS and the National Drug Code (NDC) of the product distributed:

HCPCS

Modifier

Drug

J2310

 

Naloxone injection

J2311

 

Naloxone injection, Zimhi

J3490

HG

Naloxone 4mg nasal spray

J3490

TG

Naloxone 8mg nasal spray

 

Note: When provided in the ED, take-home naloxone must be billed as a separate line item. HCA does not package naloxone when provided in the ED.

When provided by a Behavioral Health Agency, take-home naloxone must be billed as a separate claim.

See the Prescription Drug Program Billing Guide for more information.

For questions, please email us at AppleHealthPharmacyPolicy@hca.wa.gov.